- Home
- KNSA vs LGN Comparison
KNSA vs LGN Comparison
Compare KNSA & LGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- LGN
- Stock Information
- Founded
- KNSA 2015
- LGN 1963
- Country
- KNSA United Kingdom
- LGN United States
- Employees
- KNSA N/A
- LGN N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- LGN
- Sector
- KNSA Health Care
- LGN
- Exchange
- KNSA Nasdaq
- LGN Nasdaq
- Market Cap
- KNSA 2.6B
- LGN 3.1B
- IPO Year
- KNSA 2018
- LGN 2025
- Fundamental
- Price
- KNSA $35.92
- LGN $29.72
- Analyst Decision
- KNSA Strong Buy
- LGN
- Analyst Count
- KNSA 6
- LGN 0
- Target Price
- KNSA $40.83
- LGN N/A
- AVG Volume (30 Days)
- KNSA 392.6K
- LGN 3.3M
- Earning Date
- KNSA 10-28-2025
- LGN 01-01-0001
- Dividend Yield
- KNSA N/A
- LGN N/A
- EPS Growth
- KNSA N/A
- LGN N/A
- EPS
- KNSA 0.07
- LGN N/A
- Revenue
- KNSA $529,332,000.00
- LGN $2,213,862,000.00
- Revenue This Year
- KNSA $37.21
- LGN N/A
- Revenue Next Year
- KNSA $11.99
- LGN N/A
- P/E Ratio
- KNSA $542.28
- LGN N/A
- Revenue Growth
- KNSA 56.18
- LGN 77.61
- 52 Week Low
- KNSA $17.82
- LGN $26.96
- 52 Week High
- KNSA $37.34
- LGN $34.40
- Technical
- Relative Strength Index (RSI)
- KNSA 60.14
- LGN N/A
- Support Level
- KNSA $35.29
- LGN N/A
- Resistance Level
- KNSA $37.34
- LGN N/A
- Average True Range (ATR)
- KNSA 1.00
- LGN 0.00
- MACD
- KNSA -0.15
- LGN 0.00
- Stochastic Oscillator
- KNSA 65.30
- LGN 0.00
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.